• Specialization in Geographic Medicine and Tropical Diseases, VA Medical Center, San Diego, California 1997
• Specialization in Infectious Diseases, VA Medical Center San Diego, California 1995-7
• 3rd, 4th, 5th year residency in Evagelismos Hospital Arhens Greece 1992-1995
• AIDS unit, Evagelismos hospital Athens 1994
• 2nd year residency in Medicine Egio, Achaia 1991-1992
• ECFMG diploma 1991
• 1st year resident in Medicine, ΝΙΜΤΣ hospital Athens 1988-1989
• Medical officer in the Greek Army 1987-1988
• Medical school graduate, University of Patras 1986
• High school Graduate 1980

Special interests:

• Infectious Diseases
• Geographic Medicine and Travel Medicine

• Post doc in Infectious Diseases VA Medical Center University of California San Diego 1996-1998
• Post doc on Travel medicine and tropical diseases Hillcrest Hospital, University of California San Diego 1997

Fellowships, and other:

• Scientific collaborator and instructor in the Medical School of the European University of Cyprus 2017-now
• Greek represantative in the ECDC Management Board (European Center for Diseases Control), Stockholm Sweden 2012-2016
• Lecturer in the Medical School of Thessaly on Epidemiology 2005-2007
• 2000 –Thesis: « Comparative efficacy of various forms of Amphotericin B on an Aspergillus fumigatus experimental endocarditis model» Medical School, University of Athens, 2000 
• Veterans Medical Research Foundation at San Diego, fellowship 1997-8
• University of California San Diego fellowship 1996-7
• Fellowship of Hellenic State Foundation 1982-3

Membership:

• Hellenic Infectious Diseases Society
• Hellenic Society for Travel Medicine and Tropical Diseases 
• American Society of Microbiology (ASM) 
• Infectious Diseases Society of America (IDSA) 
• New York Academy of Sciences

Selected publications:

• Hense M, A Vassiloyanakopoulos, J Fierer VA San Diego Healthcare System and Department of Medicine, University of California San Diego “The importance of polymorphonuclear leukocytes in mice infected orally with Salmonella dublin” American Society of Microbiology General meeting, April 1999 Portland, Oregon 
• A Vassiloyanakopoulos and J Fierer VA San Diego Healthcare System and Department of Medicine, University of California San Diego “ PMNs are the first line of defense against Salmonella with virulence plasmids while macrophages are their place of refuge” 1997 meeting on Microbial Pathogenesis and Host Response, September 1997 Cold Spring Harbor , NewYork
• Vassiloyanakopoulos A. and J Fierer VA San Diego Healthcare System and Department of Medicine, University of California San Diego “Crucial role of polymorphonucear leykocytes (PMN) in resistance to virulent Salmonella dublin infections in mice” San Diego Medical Group Annual Meeting ,June 1997, Scripps Institution of Oceanography, San Diego California. 
• Vassiloyanakopoulos A.and J. Fierer VA San Diego Healthcare System and Department of Medicine, University of California San Diego “Crucial role of polymorphonuclear leukocytes (PMNs) in resistance to virulent Salmonella dublin infection in mice” 97 th American Society of Microbiology General Meeting , May 1997 Maimi Beach , Florida
• Saroglou G., E Mylonakis, A Vassiloyanakopoulos , A Argyropoulou, M Lazanas, E Kytea,G Chalevelakis, O Paniara, S Raptis “Prophylactic and therapeutic efficacy of liposomal Amphotericin B in experimental Aspergillus Fumigatus endocarditis” 3rd International Symposium on Modern concepts in endocarditis. Boston 1995, in the book of abstracts 
• Vassiloyanakopoulos A.,E Mylonakis, J Butsikakis, E Kytea, A Argyropoulou, M Lazanas, G Chalevelakis , G Saroglou and S Raptis: “Therapeutic efficacy of Amb and L-Amb in the Aspergillus Fumigatus rabbit endocarditis model” In the programm and Abstracts of the 6 th International Congress for in Infectious Diseases, Prague April 1994. 
• Vassiloyanakopoulos A, Falagas ME, Alamani, Michalopoulos A Henry Dunant Hospital “Aspergilus fumigates tricuspid native valve endocarditis in a non-intravenous drug user” J Med Microbiol. 2006 May;55(Pt):635-8
• German V, Vassiloyanakopoulos A,Sampaziotis D, Giannakos G “Autoimmune hepatitis in an HIV infected patient that responded to antiretroviral therapy” Scand J Infect. Dis. 2005;37(2):145-51
• Walker E., Castelli F., Fry G., Hadjichristodoulou C., Nothdurf H., Schilthius H., Tegnell A., Blystad H., Buhl M., da Cuncha S., Van Gompel A., Loutan L., Nohynek H., Vassiloyanakopoulos A., Wagner P., Walenta M. “Scientific analysis of the of infectious diseases related to tourism and travel” May 2000, edited and sponsored by the European Commission, Public Health Directorate-Communicable, rare and emerging disease unit, Health and Consumer Protection DG, Euroforum Building, L-2920 Luxembourg
• Vassiloyanakopoulos A., E. Mavrou, G Spala, Ch Hadjichristodoulou. National Center for Surveillance and Intervention, Athens Greece: “A case of tuberculosis in a long distance flight: the difficulties of the investigation” Eurosurveillance Monthly; September 1999, vol 4; 9, p96-97
• Vassiloyanakopoulos A., “ A case report study of dengue fever after a trip Southeast Asia” Hellenic Journal of Epidemiology , December 1998 Vol 1; 3, p7
• Vassiloyanakopoulos A.1, P. Tassios2, M Lampiri3. (1) National Centre for Surveillance and Intervention Athens, (2) Univ of Athens , (3)National Schoolof Public Health, National Reference Laboratory for Salmonellosis, Athens Greece: “Salmonella blockley infection in Greece” Eurosurveillance ; April 1999 , issue 15, p2-3 
• Α.Vassiloyanakopoulos and J Fierer. VA San Diego Healthcare System and Department of Medicine, University of California San Diego: “The crucial role of polymorphonuclear Leukocytes (PMN) in resistance to Salmonella dublin infections in genetically susceptible and resistant mice” The Proceedings of the National Academy of Sciences,USA June1998 Vol 95, 7676-7681.
• A Vassiloyanakopoulos, J Butsikakis, E Mylonakis, E Kytea , A Argyropoulou , M Lazanas , F Kardaras , O Paniara, G Chalevelakis, G Saroglou and S Raptis . Evagelismos Hospital, Athens Greece “Comparative therapeutic efficacy of two Amphotericin B liposomal forms in Aspergillus Fumigatus experimental endocarditis” Clinical Infectious Diseases 21:3:p779.